ViroPharma Incorporated (NASDAQ:VPHM) to Present at the Natixis Bleichroeder Hidden Gems Conference October 13

ViroPharma Incorporated (NASDAQ:VPHM) will speak at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13 at 8:30 am ET.  The presentation will be lead by ViroPharma vice president, corporate communications William Roberts.  A webcast of the presentation will be available at viropharma.com.

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases. As of December 31, 2007, the Company had one marketed product and multiple product candidates in clinical development. It markets and sells Vancocin HCl capsules, the oral capsule formulation of vancomycin hydrochloride in the United States and its territories.

ViroPharma has three development programs in its product pipeline. Two programs are in clinical development that target hepatitis C virus and cytomegalovirus (CMV) with an initial focus on CMV disease in recipients of hematopoietic stem cell/bone marrow and solid organ transplants. The third program is in preclinical development and targets the treatment and prevention of Clostridium difficile infection using the spore form of a non-toxin producing strain of C. difficile.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD provides an online global directory listing featuring public companies, stock brokers, brokerage firms and individuals.  The GMD provides profiles for Brokerage Firms, Stock Brokers and Individuals in addition to Public Companies.

The GMD is a division of TransWorldNews, Inc. Companies can utilize the TransWorldNews press release distribution services and have all news releases attached to their GMD profile.

Create your profile on The Global Market Directory.